B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by B Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,800,556
- Value
- $12.3M
- % of portfolio
- 7.0%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,800,556 | $12.3M | 7.0% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,800,556 | $8.05M | 6.0% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,800,556 | $9.90M | 7.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,800,556 | $5.89M | 5.6% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,800,556 | $4.16M | 3.6% | +545,000+43.4% | Added | Holders |
| Q1 2025 | 1,255,556 | $1.75M | 1.5% | +290,000+30.0% | Added | Holders |
| Q4 2024 | 965,556 | $1.67M | 1.0% | – | No prior filing | Holders |